Free tool

Oncology stocks

We cover 17 companies grouped under the Oncology theme. The median market value in the group is $4.34M. Across the group, the median move over the past trading day is −2.77%. Price change over the past year runs from −97.6% to −45.9% across the middle 80 percent of the group, with a median of −82.6%.

Other lists in this group

Table

17 of 319 companies match these filters.Clear filters

TickerCompanyMarket cap (USD)Size1Y return
0J4V.LHeron Therapeutics, Inc.$82.85MMicro cap−78.12%
KPTIKaryopharm Therapeutics Inc. Common Stock$44.46MMicro cap−74.90%
IMU.AXImugene Limited$25.70MMicro cap−75.00%
ABVCABVC BioPharma, Inc.$18.95MMicro cap−76.14%
RADXRadiopharm Theranostics Limited$18.29MMicro cap−58.87%
PDSBPDS Biotechnology Corporation$12.49MMicro cap−82.56%
MBRXMoleculin Biotech, Inc.$11.69MMicro cap−96.05%
APVOAptevo Therapeutics Inc.$4.34MMicro cap−92.52%
CRISCuris, Inc.$3.86MMicro cap−5.52%
RNAZTransCode Therapeutics, Inc.$2.48MMicro cap−76.72%
0RK9.LAlligator Bioscience AB (publ)$2.11MMicro cap−99.13%
SLXNSilexion Therapeutics Corp$1.97MMicro cap−95.11%
DCOYDecoy Therapeutics Inc.$1.95MMicro cap−95.78%
ATORX.STAlligator Bioscience AB (publ)$1.88MMicro cap−99.27%
BDRXBiodexa Pharmaceuticals Plc$1.07MMicro cap−96.58%
0HS8.LLisata Therapeutics, Inc.−26.55%
0K2H.LMoleculin Biotech, Inc.−94.03%

Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.

More ways to browse